Serum C-reactive Protein Levels Demonstrate Predictive Value for Radiographic and Magnetic Resonance Imaging Outcomes in Patients with Active Ankylosing Spondylitis Treated with Golimumab.

MLA

Braun, Jürgen, et al. “Serum C-Reactive Protein Levels Demonstrate Predictive Value for Radiographic and Magnetic Resonance Imaging Outcomes in Patients with Active Ankylosing Spondylitis Treated with Golimumab.” Journal of Rheumatology, vol. 43, no. 9, Sept. 2016, pp. 1704–12. EBSCOhost, https://doi.org/10.3899/jrheum.160003.

APA

Braun, J., Baraliakos, X., Hermann, K.-G. A., Xu, S., & Hsu, B. (2016). Serum C-reactive Protein Levels Demonstrate Predictive Value for Radiographic and Magnetic Resonance Imaging Outcomes in Patients with Active Ankylosing Spondylitis Treated with Golimumab. Journal of Rheumatology, 43(9), 1704–1712. https://doi.org/10.3899/jrheum.160003

Chicago

Braun, Jürgen, Xenofon Baraliakos, Kay-Geert A. Hermann, Stephen Xu, and Benjamin Hsu. 2016. “Serum C-Reactive Protein Levels Demonstrate Predictive Value for Radiographic and Magnetic Resonance Imaging Outcomes in Patients with Active Ankylosing Spondylitis Treated with Golimumab.” Journal of Rheumatology 43 (9): 1704–12. doi:10.3899/jrheum.160003.